Ma, J.; Ren, J.; Thorikay, M.; van Dinther, M.; Sanchez-Duffhues, G.; Caradec, J.; Benderitter, P.; Hoflack, J.; ten Dijke, P.
Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors. Cancers 2021, 13, 2951.
https://doi.org/10.3390/cancers13122951
AMA Style
Ma J, Ren J, Thorikay M, van Dinther M, Sanchez-Duffhues G, Caradec J, Benderitter P, Hoflack J, ten Dijke P.
Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors. Cancers. 2021; 13(12):2951.
https://doi.org/10.3390/cancers13122951
Chicago/Turabian Style
Ma, Jin, Jiang Ren, Midory Thorikay, Maarten van Dinther, Gonzalo Sanchez-Duffhues, Josselin Caradec, Pascal Benderitter, Jan Hoflack, and Peter ten Dijke.
2021. "Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors" Cancers 13, no. 12: 2951.
https://doi.org/10.3390/cancers13122951
APA Style
Ma, J., Ren, J., Thorikay, M., van Dinther, M., Sanchez-Duffhues, G., Caradec, J., Benderitter, P., Hoflack, J., & ten Dijke, P.
(2021). Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors. Cancers, 13(12), 2951.
https://doi.org/10.3390/cancers13122951